IMUC OTC
EOM Pharmaceuticals Holdings, Inc.
1W: -1.9%
1M: +13.5%
3M: -20.6%
YTD: -18.5%
1Y: +269.5%
3Y: -47.0%
5Y: -66.9%
$0.16
+0.05 (+47.22%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
+8.9% ▲
Net Income
-$2M
-1.6% ▼
EPS (Diluted)
$-0.02
+7.3% ▲
EBITDA
-$2M
-96.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $1M | $1M | $581K | $937K | $844K |
| SG&A Expenses | $1M | $2M | $1M | $1M | $984K |
| Operating Expenses | $3M | $3M | $2M | $2M | $2M |
| Operating Income | -$3M | -$3M | -$2M | -$2M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $8K | $211K | $551K | $963K | $95K |
| Income Before Tax | -$3M | -$3M | -$2M | -$2M | -$2M |
| Tax Expense | $0 | $0 | -$168K | $0 | $0 |
| Net Income | -$3M | -$3M | -$2M | -$2M | -$2M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.06 | $-0.02 | $-0.01 | $-0.02 | $-0.02 |
| EBITDA | -$1 | -$2M | -$999K | -$929K | -$2M |
| Shares Outstanding | 45M | 113M | 113M | 115M | 127M |